Medtech grows in Newark as Siemens Healthineers invests $32M in facility expansion

Siemens Healthineers, a German medtech company with a Newark hub in the Glasgow Business Community, is investing $32 million to expand its local facility by 29,000 square feet. In addition to its own investment, it will receive two grants from the Delaware Strategic Fund by the state Council on Development Finance: a Retention Grant of up to $1.3 million and a Capital Expenditure Grant of up to $690,000.

The hub, which employs 1,300 people full time, specializes in manufacturing medical imagery devices, laboratory diagnostics and healthcare IT. With the expansion, it will add more capacity to manufacture up to 20 new in vitro diagnostic assays and associated calibrator products, as well as new production equipment, according to a news release.

Company leaders say the growth will allow Siemens to reduce production outsourcing and retain well-paying jobs in Newark. It will continue to partner with the University of Delaware for internships and provide scholarships to medical technology students.

“The delivery of healthcare is evolving all over the world, including here in the United States. Expanding our operations in Delaware will allow us to better serve our customers and ultimately the patients they serve,” said Deepak Nath, president of laboratory diagnostics for Siemens Healthineers. “We have proudly been part of this community for decades, and investing in advanced medical technology here in Delaware allows us to produce products for export and better secure our supply chain for the future, while creating or preserving high-wage jobs and benefitting the community.”